Importance of comorbidity in hypopharyngeal cancer
Authors:
- 17 June 2009
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 32 (2) , 148-153
Abstract
Background.: Comorbidity has an impact on survival in laryngeal cancer in several reports. However, the importance of comorbidity in hypopharyngeal cancer (HPC) has not been reported.Methods.: A retrospective medical record review of 156 patients with HPC treated between 1995 and 2005 was performed. Comorbid illness was measured by the Adult Comorbidity Evaluation‐27. A Cox proportional hazards model was used to determine the factors related to overall survival.Results.: Comorbidity was absent in 55 (35.2%) of the patients, mild in 39 (25%), moderate in 28 (17.9%), and severe in 34 (21.8%). There were statistically significant differences between the survival rates in accord with age, stage, subsite, and comorbidity (45.1% for none or mild vs 27.7% for moderate or severe; p = .0073). Age, stage, and comorbidity were identified as independent prognostic factors in the multivariate analysis.Conclusion.: Comorbidity, along with the clinical stage, should be considered in treatment planning for patients with HPC. © 2009 Wiley Periodicals, Inc. Head Neck, 2010Keywords
This publication has 14 references indexed in Scilit:
- Comorbidity Measurement in Patients with Laryngeal Squamous Cell CarcinomaORL, 2007
- Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER databaseInternational Journal of Cancer, 2005
- Differential Prognostic Impact of ComorbidityJournal of Clinical Oncology, 2004
- Impact of comorbidity on the outcome of laryngeal squamous cancerHead & Neck, 2003
- The significance of comorbidity in advanced laryngeal cancerHead & Neck, 2001
- Importance of Comorbidity in Head and Neck CancerThe Laryngoscope, 2000
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI: Journal of the National Cancer Institute, 1996
- A Clinical-Severity Staging System for Patients with Lung CancerMedicine, 1990
- A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancerJournal of Chronic Diseases, 1986
- The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitusJournal of Chronic Diseases, 1974